Bioteque
Bioteque Corporation manufactures and sells medical device in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage… Read more
Bioteque - Asset Resilience Ratio
Bioteque (4107) has an Asset Resilience Ratio of 11.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2024)
This chart shows how Bioteque's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Bioteque's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$516.92 Million | 11.51% |
| Total Liquid Assets | NT$516.92 Million | 11.51% |
Asset Resilience Insights
- Moderate Liquidity: Bioteque has 11.51% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Bioteque Industry Peers by Asset Resilience Ratio
Compare Bioteque's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for Bioteque (2006–2024)
The table below shows the annual Asset Resilience Ratio data for Bioteque.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.75% | NT$360.09 Million | NT$4.65 Billion | +3.19pp |
| 2023-12-31 | 4.56% | NT$210.72 Million | NT$4.62 Billion | -1.02pp |
| 2022-12-31 | 5.59% | NT$250.26 Million | NT$4.48 Billion | -5.80pp |
| 2021-12-31 | 11.38% | NT$439.50 Million | NT$3.86 Billion | +3.17pp |
| 2020-12-31 | 8.21% | NT$292.60 Million | NT$3.56 Billion | +2.14pp |
| 2019-12-31 | 6.07% | NT$178.63 Million | NT$2.94 Billion | -0.36pp |
| 2018-12-31 | 6.43% | NT$178.27 Million | NT$2.77 Billion | -0.24pp |
| 2017-12-31 | 6.67% | NT$174.98 Million | NT$2.62 Billion | -0.61pp |
| 2016-12-31 | 7.28% | NT$186.68 Million | NT$2.56 Billion | -0.15pp |
| 2015-12-31 | 7.43% | NT$186.15 Million | NT$2.50 Billion | -0.29pp |
| 2014-12-31 | 7.73% | NT$181.38 Million | NT$2.35 Billion | -2.32pp |
| 2013-12-31 | 10.05% | NT$200.75 Million | NT$2.00 Billion | -10.05pp |
| 2012-12-31 | 20.10% | NT$326.94 Million | NT$1.63 Billion | +2.24pp |
| 2011-12-31 | 17.86% | NT$290.81 Million | NT$1.63 Billion | -3.12pp |
| 2010-12-31 | 20.98% | NT$353.44 Million | NT$1.69 Billion | +1.12pp |
| 2009-12-31 | 19.85% | NT$342.91 Million | NT$1.73 Billion | -0.12pp |
| 2008-12-31 | 19.98% | NT$343.94 Million | NT$1.72 Billion | +6.61pp |
| 2007-12-31 | 13.37% | NT$220.71 Million | NT$1.65 Billion | -3.29pp |
| 2006-12-31 | 16.66% | NT$218.09 Million | NT$1.31 Billion | -- |